A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns

Exclusion Criteria

• •Completely non-exuding or dry wound bed at study site
• •Full thickness \>5%
• •Burn greater than 24 hrs old
• •Burns to face or neck
• •Suspicion of infection of study burn
• •Use of chemical/enzymatic and biological debridement within 7 days of investigation start
• •Chronic steroid use, hx of skin malignancy or chronic papulosquamous disease (e.g. eczema, Pemphigus) and hx of Steven Johnson or TENS disease
• •Subject with lung injury or subject being on a ventilator
• •Subject with dermatologic skin disorders or necrotizing processes
• •Subject with insulin dependent diabetes mellitus
• •Electrical, chemical etiology
• •Diagnosed underlying disease(s) (e.g. HIV/AIDS, cancer and severe anaemia), judged by the investigator to be a potential interference in the treatment
• •Non-compliant subject
• •Subject previously included in this investigation
• •Subject included in other ongoing clinical investigation at present or during the past 30 days.